These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28632692)

  • 1. Improved 123I-Ioflupane Binding After Immunotherapy in Anti-NAE Antibody-Positive Hashimoto Encephalopathy That Clinically Mimicked Multiple System Atrophy.
    Otsuka J; Hida A; Ogyu K; Minamimoto R; Takeuchi S
    Clin Nucl Med; 2017 Aug; 42(8):e390-e391. PubMed ID: 28632692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of dementia with Lewy bodies and Hashimoto encephalopathy successfully treated with immunotherapy].
    Ikawa F; Sumi N; Nishikawa T; Maruyama H; Miyachi T
    Rinsho Shinkeigaku; 2019 Feb; 59(2):102-104. PubMed ID: 30700687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limbic encephalitis associated with anti-NH2-terminal of α-enolase antibodies: A clinical subtype of Hashimoto encephalopathy.
    Kishitani T; Matsunaga A; Ikawa M; Hayashi K; Yamamura O; Hamano T; Watanabe O; Tanaka K; Nakamoto Y; Yoneda M
    Medicine (Baltimore); 2017 Mar; 96(10):e6181. PubMed ID: 28272206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hashimoto's Encephalopathy and Autoantibodies].
    Yoneda M
    Brain Nerve; 2018 Apr; 70(4):305-314. PubMed ID: 29632279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple system atrophy with anti-NAE antibody refractory to immunotherapy: A case report.
    Ozawa M; Sakuta K; Miyagawa S; Yaguchi H
    Clin Neurol Neurosurg; 2022 Dec; 223():107504. PubMed ID: 36370600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-NAE autoantibodies and clinical spectrum in Hashimoto's encephalopathy].
    Matsunaga A; Yoneda M
    Rinsho Byori; 2009 Mar; 57(3):271-8. PubMed ID: 19363998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Case report of a patient with Hashimoto's encephalopathy associated with Basedow's disease mimicking Creutzfeldt-Jakob disease].
    Sakurai T; Tanaka Y; Koumura A; Hayashi Y; Kimura A; Hozumi I; Yoneda M; Inuzuka T
    Brain Nerve; 2008 May; 60(5):559-65. PubMed ID: 18516979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hashimoto's encephalopathy as a treatable adult-onset cerebellar ataxia mimicking spinocerebellar degeneration.
    Matsunaga A; Ikawa M; Fujii A; Nakamoto Y; Kuriyama M; Yoneda M
    Eur Neurol; 2013; 69(1):14-20. PubMed ID: 23128836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-NH2-terminal of alpha-enolase (NAE) autoantibodies].
    Matsunaga A; Yoneda M; Kuriyama M
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():648-50. PubMed ID: 20942154
    [No Abstract]   [Full Text] [Related]  

  • 10. [A Patient with Probable Dementia with Lewy Bodies and Positive Autoantibodies against the Anti-NH
    Ikura T; Fujishiro H; Takahashi Y; Yoneda M; Saito T; Chiba Y; Kamada A; Katsuse O; Hirayasu Y
    Brain Nerve; 2015 Jul; 67(7):967-72. PubMed ID: 26160824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of dopamine transporter single photon emission computed tomography imaging using I-123 ioflupane on diagnoses of patients with parkinsonian syndromes.
    Bairactaris C; Demakopoulos N; Tripsianis G; Sioka C; Farmakiotis D; Vadikolias K; Heliopoulos I; Georgoulias P; Tsougos I; Papanastasiou I; Piperidou C
    J Clin Neurosci; 2009 Feb; 16(2):246-52. PubMed ID: 19097795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The biomarker and treatment in Hashimoto's encephalopahty].
    Kishitani T; Matsunaga A; Yoneda M
    Nihon Rinsho; 2013 May; 71(5):893-7. PubMed ID: 23777101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of aging on semiquantitative uptake parameters in normal rated clinical baseline [123I]Ioflupane single photon emission computed tomography/computed tomography.
    Werner RA; Lapa C; Sheikhbahaei S; Marcus C; Solnes LB; Du Y; Leal JP; Buck AK; Higuchi T; Rowe SP; Javadi MS
    Nucl Med Commun; 2019 Oct; 40(10):1001-1004. PubMed ID: 31343608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of serum autoantibodies against the amino terminal of alpha-enolase in Hashimoto's encephalopathy.
    Yoneda M; Fujii A; Ito A; Yokoyama H; Nakagawa H; Kuriyama M
    J Neuroimmunol; 2007 Apr; 185(1-2):195-200. PubMed ID: 17335908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Undetectable specific striatal [¹²³I]-ioflupane binding in patients with parkinsonism.
    Petyt G; Kreisler A; Demailly F; Olivier A; Defebvre L; Semah F
    J Neurol Sci; 2014 Jun; 341(1-2):167-71. PubMed ID: 24814162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune encephalitis: a review of diagnosis and treatment.
    Dutra LA; Abrantes F; Toso FF; Pedroso JL; Barsottini OGP; Hoftberger R
    Arq Neuropsiquiatr; 2018 Jan; 76(1):41-49. PubMed ID: 29364393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine transporter imaging in autopsy-confirmed Parkinson's disease and multiple system atrophy.
    Perju-Dumbrava LD; Kovacs GG; Pirker S; Jellinger K; Hoffmann M; Asenbaum S; Pirker W
    Mov Disord; 2012 Jan; 27(1):65-71. PubMed ID: 22102521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-gamma-aminobutyric acid receptor type A encephalitis: a review.
    Guo CY; Gelfand JM; Geschwind MD
    Curr Opin Neurol; 2020 Jun; 33(3):372-380. PubMed ID: 32374573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal Changes on
    Kasahara H; Sato M; Nagamine S; Makioka K; Tanaka K; Ikeda Y
    Intern Med; 2019 May; 58(10):1501-1505. PubMed ID: 30713292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial brain MRI changes related to autoimmune pathophysiology in Hashimoto encephalopathy with anti-NAE antibodies: A case-series study.
    Matsunaga A; Ikawa M; Kawamura Y; Kishitani T; Yamamura O; Hamano T; Kimura H; Nakamoto Y; Yoneda M
    J Neurol Sci; 2019 Nov; 406():116453. PubMed ID: 31525528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.